A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target

A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target

Breast cancer (BC) is the most frequently occurring malignancy and the second cancer-specific cause of mortality in women in developed countries. Over 70% of the total number of BCs are hormone receptor-positive (HR+), and elevated levels of circulating estrogen (E) in the blood have been shown to b...

Full description

Bibliographic Details
Main Authors: M. Leonor Fernández-Murga, Fernando Gil-Ortiz, Lucía Serrano-García, Antonio Llombart-Cussac
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Pathogens
Subjects:
breast cancer
microbiota
estrobolome
β-glucuronidase
dysbiosis
inhibitors
Online Access:https://www.mdpi.com/2076-0817/12/9/1086

Internet

https://www.mdpi.com/2076-0817/12/9/1086

Similar Items